BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27563629)

  • 1. Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.
    Sachan R; Patel ML; Dhiman S; Gupta P; Sachan P; Shyam R
    Adv Biomed Res; 2016; 5():119. PubMed ID: 27563629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
    Leaños-Miranda A; Navarro-Romero CS; Sillas-Pardo LJ; Ramírez-Valenzuela KL; Isordia-Salas I; Jiménez-Trejo LM
    Hypertension; 2019 Oct; 74(4):991-997. PubMed ID: 31446801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
    Zhang LJ; Han YH; Han YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis values of serum STAT4 and sEng in preeclampsia.
    Zhang L; Li X; Zhou C; You Z; Zhang J; Cao G
    J Clin Lab Anal; 2020 Feb; 34(2):e23073. PubMed ID: 31628681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
    Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity.
    Nikuei P; Rajaei M; Malekzadeh K; Nejatizadeh A; Mohseni F; AtashAbParvar A
    Iran Biomed J; 2017 Sep; 21(5):312-30. PubMed ID: 28558439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
    Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
    Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.
    AbdelHalim RM; Ramadan DI; Zeyada R; Nasr AS; Mandour IA
    Mol Diagn Ther; 2016 Apr; 20(2):135-49. PubMed ID: 26790664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria.
    Osanyin GE; Okunade KS; Ayotunde Oluwole A
    Hypertens Pregnancy; 2018 May; 37(2):93-97. PubMed ID: 29718786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
    Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
    Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
    Qin W; Zhan Y; Ye YH; Li C; Cui XN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.
    Salahuddin S; Lee Y; Vadnais M; Sachs BP; Karumanchi SA; Lim KH
    Am J Obstet Gynecol; 2007 Jul; 197(1):28.e1-6. PubMed ID: 17618745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.